🇺🇸 FDA
Patent

US 10258582

Nicotinic receptor non-competitive antagonists

granted A61KA61K31/13A61K31/397

Quick answer

US patent 10258582 (Nicotinic receptor non-competitive antagonists) held by Catalyst Biosciences, Inc. expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Catalyst Biosciences, Inc.
Grant date
Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/13, A61K31/397, A61K31/40, A61P